The stock price of Stereotaxis Inc (AMEX: STXS) has dropped by -7.09 compared to previous close of 2.47. Despite this, the company has seen a gain of 3.38% in its stock price over the last five trading days. zacks.com reported 2024-12-16 that Stereotaxis’ latest regulatory approval in China is likely to offer a minimally-invasive treatment solution for complex arrhythmia patients and improve global cardiovascular care.
Is It Worth Investing in Stereotaxis Inc (AMEX: STXS) Right Now?
The stock has a 36-month beta value of 1.54. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for STXS is 69.90M, and at present, short sellers hold a 4.09% of that float. On December 27, 2024, the average trading volume of STXS was 320.26K shares.
STXS’s Market Performance
STXS stock saw an increase of 3.38% in the past week, with a monthly gain of 0.22% and a quarterly increase of 11.95%. The volatility ratio for the week is 5.46%, and the volatility levels for the last 30 days are 6.76% for Stereotaxis Inc (STXS). The simple moving average for the last 20 days is 0.32% for STXS’s stock, with a simple moving average of 7.51% for the last 200 days.
Analysts’ Opinion of STXS
Many brokerage firms have already submitted their reports for STXS stocks, with ROTH MKM repeating the rating for STXS by listing it as a “Buy.” The predicted price for STXS in the upcoming period, according to ROTH MKM is $5 based on the research report published on January 10, 2024 of the current year 2024.
Aegis Capital, on the other hand, stated in their research note that they expect to see STXS reach a price target of $6. The rating they have provided for STXS stocks is “Buy” according to the report published on July 12th, 2022.
B. Riley Securities gave a rating of “Buy” to STXS, setting the target price at $6 in the report published on June 23rd of the previous year.
STXS Trading at 8.32% from the 50-Day Moving Average
After a stumble in the market that brought STXS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.24% of loss for the given period.
Volatility was left at 6.76%, however, over the last 30 days, the volatility rate increased by 5.46%, as shares surge +3.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +18.81% upper at present.
During the last 5 trading sessions, STXS rose by +3.83%, which changed the moving average for the period of 200-days by -7.43% in comparison to the 20-day moving average, which settled at $2.29. In addition, Stereotaxis Inc saw 31.14% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at STXS starting from Isaac Paul J, who purchase 812 shares at the price of $1.88 back on Aug 19 ’24. After this action, Isaac Paul J now owns 2,767,626 shares of Stereotaxis Inc, valued at $1,527 using the latest closing price.
Isaac Paul J, the Director of Stereotaxis Inc, purchase 442 shares at $1.88 during a trade that took place back on Aug 20 ’24, which means that Isaac Paul J is holding 2,768,068 shares at $831 based on the most recent closing price.
Stock Fundamentals for STXS
Current profitability levels for the company are sitting at:
- -0.89 for the present operating margin
- 0.56 for the gross margin
The net margin for Stereotaxis Inc stands at -0.86. The total capital return value is set at -0.74. Equity return is now at value -106.46, with -45.19 for asset returns.
Based on Stereotaxis Inc (STXS), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -22.11. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is -51.89.
Currently, EBITDA for the company is -21.24 million with net debt to EBITDA at 0.21. When we switch over and look at the enterprise to sales, we see a ratio of 7.6. The receivables turnover for the company is 3.17for trailing twelve months and the total asset turnover is 0.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.39.
Conclusion
To sum up, Stereotaxis Inc (STXS) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
